Medistep Healthcare Limited is set to launch its Initial Public Offering (IPO), offering investors a chance to participate in a company that operates in the pharmaceutical sector. The company is involved in both manufacturing and trading a diverse range of products, including pharmaceuticals, intimate care, surgical, and nutraceutical items. This article provides key details about the Medistep Healthcare IPO for prospective investors, offering a deeper dive into the company’s profile, financial performance, and future plans.
This article provides key details about the Medistep Healthcare IPO details for prospective investors.
About Medistep Healthcare Ltd.
Established in 2023, Medistep Healthcare Limited is a pharmaceutical company that manufactures and trades high-quality healthcare and wellness products.
The company’s diverse product portfolio includes sanitary pads under the brand name DRYSTEP, and energy powders under the brand VITASTEP Z. They also trade a wide variety of third-party products, including pharmaceutical formulations like anti-inflammatory drugs, antibiotics, and surgical products such as cotton and bandages.
The business model is driven by orders, which helps in optimizing resources and maintaining supply efficiency. The company’s focus on quality, with a diverse product portfolio that caters to a broad customer base, is one of its core strengths.
Medistep Healthcare IPO Details
The Medistep Healthcare IPO is a Fixed Price Issue and an SME IPO aiming to raise ₹16.10 crore. It consists of a fresh issue of 37.44 lakh shares. The IPO will be listed on the NSE SME platform.
Important IPO Timeline
| Event | Date |
| IPO Open Date | Fri, Aug 8, 2025 |
| IPO Close Date | Tue, Aug 12, 2025 |
| Tentative Allotment | Wed, Aug 13, 2025 |
| Initiation of Refunds | Thu, Aug 14, 2025 |
| Credit of Shares to Demat | Thu, Aug 14, 2025 |
| Tentative Listing Date | Mon, Aug 18, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Aug 12, 2025 |
Key IPO Details
| Event | Details |
| IPO Date | August 8, 2025 to August 12, 2025 |
| Listing Date | – |
| Face Value | ₹10 per share |
| Issue Price | ₹43 per share |
| Lot Size | 3,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 37,44,000 shares (aggregating up to ₹16.10 Cr) |
| Reserved for Market Maker | 1,89,000 shares (aggregating up to ₹0.8127 Cr) |
| Net Offered to Public | 35,55,000 shares (aggregating up to ₹15.29 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Shareholding (Pre-Issue) | 1,04,65,546 shares |
| Shareholding (Post-Issue) | 1,42,09,546 shares |
Lot Size of Medistep Healthcare
| Application | Lots | Shares | Amount |
| Individual investors (Retail) (Min) | 2 | 6,000 | ₹2,58,000 |
| Individual investors (Retail) (Max) | 2 | 6,000 | ₹2,58,000 |
| HNI (Min) | 3 | 9,000 | ₹3,87,000 |
Medistep Healthcare Ltd. Financials
The company has demonstrated impressive financial growth. The total income for FY25 stood at ₹49.66 crore, a significant increase from ₹31.63 crore in FY24. Profit After Tax (PAT) also saw a substantial rise, from ₹2.91 crore in FY24 to ₹4.14 crore in FY25. This growth highlights the company’s strong operational performance and effective management.
Key Performance Indicators (as of March 31, 2025)
- ROE: 29.06%
- ROCE: 32.88%
- Debt/Equity: 0.04
- PAT Margin: 8.34%
- EBITDA Margin: 11.28%
Use of IPO Proceeds
The funds raised from the IPO are intended for several strategic purposes, including:
| S.No. | Purpose of the Issue | Estimated Amount (₹ in crores) |
| 1 | Allocation for capital expenditure to acquire plant and machinery for expansion at the current manufacturing site | 0.51 |
| 2 | Requirement for working capital | 12.34 |
| 3 | General corporate purposes | 2 |
Medistep Healthcare IPO Peer Comparison
Medistep Healthcare Limited operates in the competitive pharmaceutical and wellness segment. Its key competitors including Fabino Enterprises Limited and Achyut Healthcare Limited. Similar to Medistep Healthcare, these companies are engaged in the production and supply of healthcare products, catering to industries such as pharmaceuticals, medical equipment, and health services. Their broad product range and emphasis on quality make them relevant for comparison within the healthcare domain.
Conclusion
The Medistep Healthcare IPO presents an investment opportunity in a growing sector of the healthcare industry. The company’s focus on both manufacturing and trading, coupled with its strong financial performance, makes it an interesting prospect. Investors should carefully evaluate the company’s financials, the use of IPO proceeds, and the competitive landscape before making an investment decision.
If you are exploring more investment opportunities, check out our dedicated page on upcoming IPO listings to stay updated on the latest market offerings.
